GlassScriptPhysician profile
Alan H Gross
NPI 1194745869
$7,242.02
in general payments reported to CMS, 2019-2025
44 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,141 · 2020: $631 · 2021: $647 · 2022: $675 · 2023: $1,334 · 2024: $1,279 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,147.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,862.27 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,467.74 | 2019-2024 | Fasenra, Farxiga, Airsupra |
| Pfizer INC. | $525.41 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $471.36 | 2019-2023 | Stiolto Respimat, Spiriva Respimat, Jardiance |
| Janssen Pharmaceuticals, INC | $399.47 | 2019-2023 | Xarelto |
| Mylan Specialty L.P. | $328.03 | 2019-2024 | Yupelri |
| Lilly USA, LLC | $230.75 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $209.32 | 2023-2025 | Cologuard Collection Kit |
| Baxter Healthcare | $196.29 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novo Nordisk INC | $140.56 | 2019-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $109.79 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Kowa Pharmaceuticals America, INC. | $99.15 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $95.28 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.50 | 2024 | Glassia |
| Astellas Pharma US INC | $63.82 | 2019-2023 | Veozah |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.